UNSPSC 51281808: Esorubicin

This classification denotes an anthracycline antibiotic with the molecular formula C27H29NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, RMC41L2WQ3 chemically known as 5,12-naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2h-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (2s-(2.alpha,(8r*,10r*),4.beta.,6.beta))- but generally known as esorubicin, which bears US NIH Compound Identifier 44554.

UNSPSC 51281808 Esorubicin is a Commodity code that in practice covers a broader range of pharmaceutical and medical products state and local governments procure, including naloxone, medical and first aid supplies, generic pharmaceuticals, and over-the-counter products for emergency response, public health, and healthcare facility operations. Recent solicitations show state and local buyers purchasing emergency medical supplies, pharmacy benefit management services, and pharmaceutical products through both direct procurement and cooperative purchasing arrangements. The issuing bodies span county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The activity reflects procurement focused on supporting emergency response operations, community health initiatives, and state employee and retiree health plans.

Recent activity concentrates in Florida, Texas, and the Upper Midwest, with secondary activity across states participating in cooperative purchasing vehicles. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's ITB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) seeking vendor capabilities for a direct-to-manufacturer prescription program; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities. The Tampa procurement includes a 5 percent bid discount set-aside for certified Small Local Business Enterprises, while the MMCAP RFP requires compliance with cGMP, DSCSA, and FDA requirements with an administrative fee of 3 percent on contract purchases.